Back To Search Results

Dr Marvin Chua Wei Jie

MBBS (Singapore), MRCP (UK)

Consultant

Sengkang General Hospital

Specialty: Endocrinology

Conditions Treated by this Doctor:
Diabetes Mellitus, Lipid disorders, Obesity, Thyroid Disorders.

Clinical Appointments

Consultant SingHealth Duke-NUS Diabetes Centre
Consultant Department of Endocrinology Sengkang General Hospital
Consultant Department of General Medicine Sengkang General Hospital

Profile

Dr Marvin Chua is a Consultant in Endocrinology in the Department of General Medicine at Sengkang General Hospital. He received his medical degree from the National University of Singapore, completed his advanced specialty training in Endocrinology at National University Hospital and joined Sengkang General Hospital in 2018. Dr Chua sees a wide range of Endocrinology conditions including Diabetes Mellitus, thyroid disorders and osteoporosis, and has a subspecialty interest in obesity and lipid disorders.

Dr Chua is an integral member of the multidisciplinary Sengkang General Hospital Weight Improvement Therapy and Complete Health (SWITCH) program. He is a firm believer of the importance of public education and has given several public talks on obesity in both English and Mandarin, as well as a live radio interview. He has several research publications in the area of obesity, including the "clash of the two pandemics" – obesity and COVID-19 – and its far-reaching impact on both the patient and physician. In addition, Dr Chua is involved in the Familial Hypercholesterolemia Case identification, Assessment and Reduction in Adverse Events (FH-CARE) study, which is a national program for the screening of Familial Hypercholesterolemia (FH). FH is a genetic disease that leads to high cholesterol levels and increases the risk of heart disease in young people, thus early diagnosis and treatment is essential.

Dr Chua has a keen interest in education – recognizing that obesity is an important topic which often does not receive adequate emphasis, he seeks to actively incorporate this into his teaching at both the undergraduate and postgraduate level.

Education

MBBS (Singapore)
MRCP (UK)
Certificate of Specialist Accreditation in Endocrinology (Singapore)

Professional Appointments and Committee Memberships

Honorary Secretary, Singapore Association for the Study of Obesity (SASO)
Honorary Treasurer, Endocrine and Metabolic Society of Singapore (EMSS)
Clinical Lecturer, NUS Yong Loo Lin School of Medicine
Clinical Faculty, Duke NUS Medicine

Awards

You Sparkle! Award Gold, 2022
10 years long service award, 2021

Research Interests

Publications

1. The Invisible and Insidious Enemy
Marvin Wei Jie Chua
Obesity Surgery, 2021 Jul 2; doi: 10.1007/s11695-021-05550-3.

2. Obesity and COVID-19: Take Two-Has Our Saw Been Adequately Sharpened?
Marvin Wei Jie Chua
Obesity Surgery, 2021 Jun 9;1-2. doi: 10.1007/s11695-021-05506-7.

3. More than meets the eye: a patient with hand swelling and newly diagnosed Diabetes Mellitus
Tin Kyaw Kyaw Aung, Chuah Tyng Yu, Marvin Wei Jie Chua
The American Journal of Medicine. 2021 Jun 5;S0002-9343(21)00359-4. doi: 10.1016/j.amjmed.2021.05.009.

4. Bilateral Peroneal Neuropathy in a Patient with Gastric Remnant Twist Following Laparoscopic Sleeve Gastrectomy
Marvin Wei Jie Chua, Bin Chet Toh
Obesity Surgery, 2021 May 18. doi: 10.1007/s11695-021-05476-w.

5. A Fortunate Escape After Falling into a Ravine: a Case of Wernicke Encephalopathy, Polyneuropathy and Optic Neuropathy Following Sleeve Gastrectomy
Marvin Wei Jie Chua, Baldwin Po Man Yeung
Obesity Surgery, 2021 May 12. doi: 10.1007/s11695-021-05471-1.

6. Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery
Marvin Wei Jie Chua, Boon Cheok Lai
Obesity Surgery, Apr 22 2021. doi: 10.1007/s11695-021-05438-2.

7. SGLT2 inhibitors as calorie restriction-mimetics: insights on longevity pathways and age-related diseases
Caroline Hoong, Marvin Wei Jie Chua
Endocrinology, Apr 15 2021;bqab079. doi: 10.1210/endocr/bqab079.

8. Early onset of acute pancreatitis in a patient on low-dose liraglutide
Marvin Wei Jie Chua, Yi Kang Ng
Diabetes & Metabolic Syndrome, Mar 24 2021;15(3):753-755. doi: 10.1016/j.dsx.2021.03.010.

9. Adipsic diabetes insipidus and SGLT2 inhibitor: A perplexing conundrum
Marvin Wei Jie Chua, Donovan Tay, Yee Sien Ng, C Rajasoorya
Annals of the Academy of Medicine Singapore, Feb 2021;50(2):181-183. doi: 10.47102/annals-acadmedsg.2020418.

10. Delayed Onset of Central Hypocortisolism in a Patient Recovering From COVID-19
Marvin Wei Jie Chua, Melvin Chua
AACE Clinical Case Reports, Jan-Feb 2021;7(1):2-5. doi: 10.1016/j.aace.2020.11.001.

11. Managing patients with obesity in the post COVID-19 world: Time to sharpen the saw
Marvin Wei Jie Chua
Obesity Research & Clinical Practice, Jan-Feb 2021;15(1):85-88. doi: 10.1016/j.orcp.2020.11.008.

12. Amiodarone Induced Thyrotoxicosis and Treatment Complications in a Man With Cyanotic Congenital Heart Disease: A Case Report
Marvin Wei Jie Chua, Mok Shao Feng
Frontiers in Cardiovascular Medicine, Oct 30 2020, 7:574391. doi: 10.3389/fcvm.2020.574391.

13. Obesity and COVID-19: The clash of two pandemics
Marvin Wei Jie Chua, Shuwei Zheng
Obesity Research & Clinical Practice, Jul-Aug 2020;14(4): 380-382. doi: 10.1016/j.orcp.2020.06.003.

14. The Great Masquerador: A Young Female with Multiple Endocrine Neoplasia Type 2A and Bilateral Pheochromocytomas
Marvin Wei Jie Chua, Kathleen Sek, E Shyong Tai
The American Journal of Medicine, Nov 2019, 132(11): e767-e770. doi: 10.1016/j.amjmed.2019.04.034.

15. Hyponatremia: An Unusual Link to a Common Encounter
Raymond Goh, Brenda Chiang, Marvin Wei Jie Chua, Chaw Su Naing
The American Journal of Medicine, Apr 2019, 132(4): e535-e537. doi: 10.1016/j.amjmed.2018.11.025.

Research Trials

Tags: Endocrinology, Diabetes Mellitus, Lipid disorders, Obesity, Thyroid Disorders